Could this be the ultimate solution for obesity and diabetes
Understanding Semaglutide Semaglutide is an FDA-approved medication specifically designed for weight management in adults dealing with obesity or who are overweight with additional health issues
For example, in the study we cited where berberine went up against metformin, 35% of subjects had significant gastrointestinal upset when taking the 1,500 mg/day dose (three capsules worth)
Taking all this data together it seems logical or appropriate to conclude that, because IGF1-R has a different signalling pathway that can maintain lipid oxidation in the liver, FFA uptake in muscle, and activates mTORC1 could reactivate IR through tyrosine kinase activity on IRS, thus displacing serine phosphorylation, reinstituting insulin signalling
PRP: Requires clinic visits and blood draw
Quantification and statistics Results were expressed as mean standard error of the mean (mean SEM)